Keywords: Genetic, Cancer, Retinoblastoma


Retinoblastoma (RB) is a uncommon childhood malignant ailment induced by means of the biallelic inactivation of RB1 gene. Early analysis and identification of carriers of heritable RB1 mutations can enhance sickness effect and management. In this study, mutational evaluation used to be performed on fifty-nine matched tumor and peripheral blood samples from 18 bilateral and forty one unilateral unrelated RB instances by means of a combinatorial strategy of Multiplex Ligation-dependent Probe Amplification (MLPA) assay, deletion screening, direct sequencing, replica wide variety gene dosage evaluation and methylation assays. Screening of each blood and tumor samples yielded a mutation detection charge of 94.9% (56/59) whilst solely 42.4% (25/59) of mutations had been detected if blood samples on my own had been analyzed. Biallelic mutations had been discovered in 43/59 (72.9%) of tumors screened. There have been three instances (5.1%) in which no mutations may want to be detected and germline mutations have been detected in 19.5% (8/41) of unilateral cases. A whole of sixty one factor mutations have been identified, of which 10 had been novel. There was once a excessive incidence of in the past stated recurrent mutations, taking place at 38.98% (23/59) of all cases. Of pastime had been three instances of mosaic RB1 mutations detected in the blood from sufferers with unilateral retinoblastoma. Our findings additionally underscore the significance of genetic checking out in aiding individualized disorder administration plans for sufferers and asymptomatic household individuals carrying low-penetrance, germline mosaicism or heritable unilateral mutational phenotypes.


Download data is not yet available.


Benavente CA, Dyer MA. Genetics and Epigenetics of Human Retinoblastoma. Annu Rev Pathol Mech Dis. 2015;10: 547–562. 10.1146/annurev-pathol-012414-040259 [PubMed] [CrossRef] [Google Scholar]
Bowles E, Corson TW, Bayani J, Squire JA, Wong N, Lai PBS, et al. Profiling genomic copy number changes in retinoblastoma beyond loss of RB1. Genes Chromosom Cancer. 2007;46: 118–129. 10.1002/gcc.20383 [PubMed] [CrossRef] [Google Scholar]
Bookstein R, Lai CC, Hoang T, Lee WH. PCR-based detection of a polymorphic BamHI site in intron 1 of the human retinoblastoma (RB) gene. Nucleic Acids Res. 1990;18: 1666 10.1093/nar/18.6.1666 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Canzian F, Salovaara R, Hemminki A, Kristo P, Chadwick RB, Aaltonen LA, et al. Semiautomated assessment of loss of heterozygosity and replication error in tumors. Cancer Res. 1996;56: 3331–3337. Available: [PubMed] [Google Scholar]
Choy KW, Pang CP, To KF, Yu CBO, Ng JSK, Lam DSC. Impaired expression and promotor hypermethylation of O6-methylguanine-DNA methyltransferase in retinoblastoma tissues. Investig Ophthalmol Vis Sci. 2002;43: 1344–1349. Available: [PubMed] [Google Scholar]
Chen D, Gallie BL, Squire JA. Minimal regions of chromosomal imbalance in retinoblastoma detected by comparative genomic hybridization. Cancer Genet Cytogenet. 2001;129: 57–63. 10.1016/S0165-4608(01)00427-7 [PubMed] [CrossRef] [Google Scholar]
Dimaras H, Kimani K, Dimba EAO, Gronsdahl P, White A, Chan HSL, et al. Retinoblastoma. Lancet. 2012;379: 1436–1440. 10.1016/S0140-6736(11)61137-9 [PubMed] [CrossRef] [Google Scholar]
Dimaras H, Corson TW, Cobrinik D, White A, Zhao J, Munier FL, et al. Retinoblastoma. Nat Rev Dis Prim. 2015; 15062 10.1038/nrdp.2015.62 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Dimaras H, Corson TW, Cobrinik D, White A, Zhao J, Munier FL, et al. Retinoblastoma. Nat Rev Dis Prim. 2015; 15062 10.1038/nrdp.2015.62 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Grasemann C, Gratias S, Stephan H, Schüler A, Schramm A, Klein-Hitpass L, et al. Gains and overexpression identify DEK and E2F3 as targets of chromosome 6p gains in retinoblastoma. Oncogene. University Children’s Hospital of Essen, Universitätsklinikum Essen, D-45122 Essen, Germany, England; 2005;24: 6441–6449. 10.1038/sj.onc.1208792 [PubMed] [CrossRef] [Google Scholar]
Hogg A, Onadim Z, Baird PN, Cowell JK. Detection of heterozygous mutations in the RB1 gene in retinoblastoma patients using single-strand conformation polymorphism analysis and polymerase chain reaction sequencing. Oncogene. 1992;7: 1445–1451. Available: [PubMed] [Google Scholar]
Horsthemke B, Greger V, Becher R, Passarge E. Mechanism of i(6p) formation in retinoblastoma tumor cells. Cancer Genet Cytogenet. 1989;37: 95–102. 10.1016/0165-4608(89)90079-4 [PubMed] [CrossRef] [Google Scholar]
Kivela T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol. 2009;93: 1129–1131. 10.1136/bjo.2008.150292 [PubMed] [CrossRef] [Google Scholar]
Kooi IE, Mol BM, Massink MPG, De Jong MC, De Graaf P, Van Der Valk P, et al. A meta-analysis of retinoblastoma copy numbers refines the list of possible driver genes involved in tumor progression. PLoS One. Department of Clinical Genetics, VU University Medical Center, Amsterdam, Netherlands; 2016;11: e0153323 10.1371/journal.pone.0153323 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Laurie NA, Donovan SL, Shih C-S, Zhang J, Mills N, Fuller C, et al. Inactivation of the p53 pathway in retinoblastoma. Nature. Nature Publishing Group; 2006;444: 61–66. 10.1038/nature05194 [PubMed] [CrossRef] [Google Scholar]
Lim FPM, Soh SY, Iyer JV, Tan AM, Swati H, Quah BL. Clinical Profile, Management, and Outcome of Retinoblastoma in Singapore. J Pediatr Ophthalmol Strabismus. 2013;50: 106–112. 10.3928/01913913-20121211-01 [PubMed] [CrossRef] [Google Scholar]
Lohmann DR, Gallie BL. Retinoblastoma: Revisiting the model prototype of inherited cancer [Internet]. American Journal of Medical Genetics. 2004. pp. 23–28. 10.1002/ajmg.c.30024 [PubMed] [CrossRef] [Google Scholar]
Marchong MN, Chen D, Corson TW, Lee C, Harmandayan M, Bowles E, et al. Minimal 16q genomic loss implicates cadherin-11 in retinoblastoma. Mol Cancer Res. 2004;2: 495–503. 2/9/495 [pii] [PubMed] [Google Scholar]
Mendoza PR, Grossniklaus HE. The Biology of Retinoblastoma. Prog Mol Biol Transl Sci. Department of Ophthalmology, Emory University, School of Medicine, Atlanta, GA, United States; 2015;134: 503–516. 10.1016/bs.pmbts.2015.06.012 [PubMed] [CrossRef] [Google Scholar]
Mol BM, Massink MPG, van der Hout AH, Dommering CJ, Zaman JMA, Bosscha MI, et al. High resolution SNP array profiling identifies variability in retinoblastoma genome stability. Genes Chromosom Cancer. Department of Clinical Genetics, VU University Medical Center, Amsterdam, Netherlands; 2014;53: 1–14. 10.1002/gcc.22111 [PubMed] [CrossRef] [Google Scholar]
McEvoy J, Flores-Otero J, Zhang J, Nemeth K, Brennan R, Bradley C, et al. Coexpression of Normally Incompatible Developmental Pathways in Retinoblastoma Genesis. Cancer Cell. United States: NIH Public Access; 2011;20: 260–275. 10.1016/j.ccr.2011.07.005 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16: 1215 10.1093/nar/16.3.1215 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Mcgee TL, Cowley GS, Yandell DW, Dryja TP. Detection of the Xbal RFLP within the retinoblastoma locus by PCR. Nucleic Acids Res. 1990;18: 207 10.1093/nar/18.1.207-a [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Priya K, Jada SR, Boon LQ, Thuan CQ, Poh SL. High incidence of allelic loss at 16q12.2 region spanning RBL2/p130 gene in retinoblastoma. Cancer Biol Ther. Division of Human Genetics, Department of Paediatrics, National University of Singapore, Singapore, Singapore: Taylor & Francis; 2009;8: 714–717. 10.4161/cbt.8.8.7921 [CrossRef] [Google Scholar]
Rowland JS, Barton DE, Taylor GR. A comparison of methods for gene dosage analysis in HMSN type 1. J Med Genet. 2001;38: 90–5. 10.1136/jmg.38.2.90 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Rushlow DE, Mol BM, Kennett JY, Yee S, Pajovic S, Thériault BL, et al. Characterisation of retinoblastomas without RB1 mutations: Genomic, gene expression, and clinical studies. Lancet Oncol. Impact Genetics and the Toronto Western Hospital Research Institute, University Health Network, Toronto, ON, Canada; 2013;14: 327–334. 10.1016/S1470-2045(13)70045-7 [PubMed] [CrossRef] [Google Scholar]
Stirzaker C, Millar DS, Paul CL, Warnecke PM, Harrison J, Vincent PC, et al. Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors. Cancer Res. 1997;57: 2229–2237. Available: [PubMed] [Google Scholar]
Toguchida J, Ishizaki K, Sasaki MS. Mutation Spectrum of the Retinoblastoma Gene in Osteosarcomas. Cancer Res. 1994;54: 3042–3048. Available: [PubMed] [Google Scholar]
Vaughn GL, Toguchida J, Mcgee T, Dryja TP. Pcr detection of the Tth 111 I RFLP at the RB locus. Nucleic Acids Res. Oxford University Press; 1990;18: 4965 10.1093/nar/18.16.4965 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Yau SC, Bobrow M, Mathew CG, Abbs SJ. Accurate diagnosis of carriers of deletions and duplications in Duchenne/Becker muscular dystrophy by fluorescent dosage analysis. J Med Genet. 1996;33: 550–8. 10.1136/jmg.33.7.550 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Zeschnigk M, Lohmann D, Horsthemke B. A PCR test for the detection of hypermethylated alleles at the retinoblastoma locus. J Med Genet. 1999;36: 793–4. Available: [PMC free article] [PubMed] [Google Scholar]
How to Cite
AMALIAH, L., & SUYANTO, J. (2021). GENETIC IN CANCER: RB1 MUTATIONS IN RETINOBLASTOMA CASES. Journal of Nursing and Public Health, 9(1), 47-53. Retrieved from